Review



il 36γ  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems il 36γ
    Il 36γ, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 36γ/product/R&D Systems
    Average 93 stars, based on 13 article reviews
    il 36γ - by Bioz Stars, 2026-06
    93/100 stars

    Images



    Similar Products

    93
    MedChemExpress il 36γ plus fapi 4 group
    Il 36γ Plus Fapi 4 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 36γ plus fapi 4 group/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    il 36γ plus fapi 4 group - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    86
    Adipogen il 36γ il 1f9
    IL-36 is elevated in severe bronchiolitis only and is positively correlated with the length of hospitalisation. A) Expression of IL36A , IL36B , and IL36G in moderate (n = 21) and severe (n = 21) bronchiolitis , in RNA isolated from NPAs, and measured by NanoString. B) IL-36 protein levels in nasopharyngeal aspirates from either moderate ( n = 48) or severe ( n = 40) bronchiolitis. C) IL-36 protein levels in nasopharyngeal aspirates (RSV + group) from either moderate (n = 20) or severe (n = 20) RSV infection. D) Protein concentrations of IL-36α in nasosorption samples from healthy controls (grey squares; n = 15), moderate bronchiolitis (blue circles; n = 13) or severe bronchiolitis (red triangles; n = 36). E) Gene expression of IL36A was measured in blood using bulk transcriptomics in healthy infants ( n = 56), or infants with mild ( n = 72), moderate ( n = 92) or severe ( n = 48) RSV infection ( https://doi.org/10.1002/ctm2.1507) . (F) Spearman’s non-parametric correlation and simple linear regression between IL and 36α concentration and the length of hospitalisation. (G) Heatmap of Z-scores of 13 protein mediators measured in NPAs. Both rows and columns were split by K-means clustering. Patients are annotated with peak severity (blue = moderate, red = severe), age, and length of hospital stay (LOS). In panel A the line at y = 5.36 represents the threshold for gene expression after background thresholding, A chi-squared test in panel A determined significant increase in expression above the background threshold, and Mann-Whitney test determined significance between severe and moderate infection in panels A–C. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Il 36γ Il 1f9, supplied by Adipogen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 36γ il 1f9/product/Adipogen
    Average 86 stars, based on 1 article reviews
    il 36γ il 1f9 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    93
    R&D Systems il 36γ
    IL-36 is elevated in severe bronchiolitis only and is positively correlated with the length of hospitalisation. A) Expression of IL36A , IL36B , and IL36G in moderate (n = 21) and severe (n = 21) bronchiolitis , in RNA isolated from NPAs, and measured by NanoString. B) IL-36 protein levels in nasopharyngeal aspirates from either moderate ( n = 48) or severe ( n = 40) bronchiolitis. C) IL-36 protein levels in nasopharyngeal aspirates (RSV + group) from either moderate (n = 20) or severe (n = 20) RSV infection. D) Protein concentrations of IL-36α in nasosorption samples from healthy controls (grey squares; n = 15), moderate bronchiolitis (blue circles; n = 13) or severe bronchiolitis (red triangles; n = 36). E) Gene expression of IL36A was measured in blood using bulk transcriptomics in healthy infants ( n = 56), or infants with mild ( n = 72), moderate ( n = 92) or severe ( n = 48) RSV infection ( https://doi.org/10.1002/ctm2.1507) . (F) Spearman’s non-parametric correlation and simple linear regression between IL and 36α concentration and the length of hospitalisation. (G) Heatmap of Z-scores of 13 protein mediators measured in NPAs. Both rows and columns were split by K-means clustering. Patients are annotated with peak severity (blue = moderate, red = severe), age, and length of hospital stay (LOS). In panel A the line at y = 5.36 represents the threshold for gene expression after background thresholding, A chi-squared test in panel A determined significant increase in expression above the background threshold, and Mann-Whitney test determined significance between severe and moderate infection in panels A–C. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Il 36γ, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 36γ/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    il 36γ - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    86
    Moderna il 36γ
    IL-36 is elevated in severe bronchiolitis only and is positively correlated with the length of hospitalisation. A) Expression of IL36A , IL36B , and IL36G in moderate (n = 21) and severe (n = 21) bronchiolitis , in RNA isolated from NPAs, and measured by NanoString. B) IL-36 protein levels in nasopharyngeal aspirates from either moderate ( n = 48) or severe ( n = 40) bronchiolitis. C) IL-36 protein levels in nasopharyngeal aspirates (RSV + group) from either moderate (n = 20) or severe (n = 20) RSV infection. D) Protein concentrations of IL-36α in nasosorption samples from healthy controls (grey squares; n = 15), moderate bronchiolitis (blue circles; n = 13) or severe bronchiolitis (red triangles; n = 36). E) Gene expression of IL36A was measured in blood using bulk transcriptomics in healthy infants ( n = 56), or infants with mild ( n = 72), moderate ( n = 92) or severe ( n = 48) RSV infection ( https://doi.org/10.1002/ctm2.1507) . (F) Spearman’s non-parametric correlation and simple linear regression between IL and 36α concentration and the length of hospitalisation. (G) Heatmap of Z-scores of 13 protein mediators measured in NPAs. Both rows and columns were split by K-means clustering. Patients are annotated with peak severity (blue = moderate, red = severe), age, and length of hospital stay (LOS). In panel A the line at y = 5.36 represents the threshold for gene expression after background thresholding, A chi-squared test in panel A determined significant increase in expression above the background threshold, and Mann-Whitney test determined significance between severe and moderate infection in panels A–C. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Il 36γ, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 36γ/product/Moderna
    Average 86 stars, based on 1 article reviews
    il 36γ - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    96
    Bio-Rad antibodies against il 36γ
    IL-36 is elevated in severe bronchiolitis only and is positively correlated with the length of hospitalisation. A) Expression of IL36A , IL36B , and IL36G in moderate (n = 21) and severe (n = 21) bronchiolitis , in RNA isolated from NPAs, and measured by NanoString. B) IL-36 protein levels in nasopharyngeal aspirates from either moderate ( n = 48) or severe ( n = 40) bronchiolitis. C) IL-36 protein levels in nasopharyngeal aspirates (RSV + group) from either moderate (n = 20) or severe (n = 20) RSV infection. D) Protein concentrations of IL-36α in nasosorption samples from healthy controls (grey squares; n = 15), moderate bronchiolitis (blue circles; n = 13) or severe bronchiolitis (red triangles; n = 36). E) Gene expression of IL36A was measured in blood using bulk transcriptomics in healthy infants ( n = 56), or infants with mild ( n = 72), moderate ( n = 92) or severe ( n = 48) RSV infection ( https://doi.org/10.1002/ctm2.1507) . (F) Spearman’s non-parametric correlation and simple linear regression between IL and 36α concentration and the length of hospitalisation. (G) Heatmap of Z-scores of 13 protein mediators measured in NPAs. Both rows and columns were split by K-means clustering. Patients are annotated with peak severity (blue = moderate, red = severe), age, and length of hospital stay (LOS). In panel A the line at y = 5.36 represents the threshold for gene expression after background thresholding, A chi-squared test in panel A determined significant increase in expression above the background threshold, and Mann-Whitney test determined significance between severe and moderate infection in panels A–C. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Antibodies Against Il 36γ, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against il 36γ/product/Bio-Rad
    Average 96 stars, based on 1 article reviews
    antibodies against il 36γ - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    93
    Proteintech il 36γ
    IL-36 is elevated in severe bronchiolitis only and is positively correlated with the length of hospitalisation. A) Expression of IL36A , IL36B , and IL36G in moderate (n = 21) and severe (n = 21) bronchiolitis , in RNA isolated from NPAs, and measured by NanoString. B) IL-36 protein levels in nasopharyngeal aspirates from either moderate ( n = 48) or severe ( n = 40) bronchiolitis. C) IL-36 protein levels in nasopharyngeal aspirates (RSV + group) from either moderate (n = 20) or severe (n = 20) RSV infection. D) Protein concentrations of IL-36α in nasosorption samples from healthy controls (grey squares; n = 15), moderate bronchiolitis (blue circles; n = 13) or severe bronchiolitis (red triangles; n = 36). E) Gene expression of IL36A was measured in blood using bulk transcriptomics in healthy infants ( n = 56), or infants with mild ( n = 72), moderate ( n = 92) or severe ( n = 48) RSV infection ( https://doi.org/10.1002/ctm2.1507) . (F) Spearman’s non-parametric correlation and simple linear regression between IL and 36α concentration and the length of hospitalisation. (G) Heatmap of Z-scores of 13 protein mediators measured in NPAs. Both rows and columns were split by K-means clustering. Patients are annotated with peak severity (blue = moderate, red = severe), age, and length of hospital stay (LOS). In panel A the line at y = 5.36 represents the threshold for gene expression after background thresholding, A chi-squared test in panel A determined significant increase in expression above the background threshold, and Mann-Whitney test determined significance between severe and moderate infection in panels A–C. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Il 36γ, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 36γ/product/Proteintech
    Average 93 stars, based on 1 article reviews
    il 36γ - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    86
    Novoprotein il 36γ group
    IL-36 is elevated in severe bronchiolitis only and is positively correlated with the length of hospitalisation. A) Expression of IL36A , IL36B , and IL36G in moderate (n = 21) and severe (n = 21) bronchiolitis , in RNA isolated from NPAs, and measured by NanoString. B) IL-36 protein levels in nasopharyngeal aspirates from either moderate ( n = 48) or severe ( n = 40) bronchiolitis. C) IL-36 protein levels in nasopharyngeal aspirates (RSV + group) from either moderate (n = 20) or severe (n = 20) RSV infection. D) Protein concentrations of IL-36α in nasosorption samples from healthy controls (grey squares; n = 15), moderate bronchiolitis (blue circles; n = 13) or severe bronchiolitis (red triangles; n = 36). E) Gene expression of IL36A was measured in blood using bulk transcriptomics in healthy infants ( n = 56), or infants with mild ( n = 72), moderate ( n = 92) or severe ( n = 48) RSV infection ( https://doi.org/10.1002/ctm2.1507) . (F) Spearman’s non-parametric correlation and simple linear regression between IL and 36α concentration and the length of hospitalisation. (G) Heatmap of Z-scores of 13 protein mediators measured in NPAs. Both rows and columns were split by K-means clustering. Patients are annotated with peak severity (blue = moderate, red = severe), age, and length of hospital stay (LOS). In panel A the line at y = 5.36 represents the threshold for gene expression after background thresholding, A chi-squared test in panel A determined significant increase in expression above the background threshold, and Mann-Whitney test determined significance between severe and moderate infection in panels A–C. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Il 36γ Group, supplied by Novoprotein, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 36γ group/product/Novoprotein
    Average 86 stars, based on 1 article reviews
    il 36γ group - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    93
    Proteintech il 36γ antibody
    IL-36 is elevated in severe bronchiolitis only and is positively correlated with the length of hospitalisation. A) Expression of IL36A , IL36B , and IL36G in moderate (n = 21) and severe (n = 21) bronchiolitis , in RNA isolated from NPAs, and measured by NanoString. B) IL-36 protein levels in nasopharyngeal aspirates from either moderate ( n = 48) or severe ( n = 40) bronchiolitis. C) IL-36 protein levels in nasopharyngeal aspirates (RSV + group) from either moderate (n = 20) or severe (n = 20) RSV infection. D) Protein concentrations of IL-36α in nasosorption samples from healthy controls (grey squares; n = 15), moderate bronchiolitis (blue circles; n = 13) or severe bronchiolitis (red triangles; n = 36). E) Gene expression of IL36A was measured in blood using bulk transcriptomics in healthy infants ( n = 56), or infants with mild ( n = 72), moderate ( n = 92) or severe ( n = 48) RSV infection ( https://doi.org/10.1002/ctm2.1507) . (F) Spearman’s non-parametric correlation and simple linear regression between IL and 36α concentration and the length of hospitalisation. (G) Heatmap of Z-scores of 13 protein mediators measured in NPAs. Both rows and columns were split by K-means clustering. Patients are annotated with peak severity (blue = moderate, red = severe), age, and length of hospital stay (LOS). In panel A the line at y = 5.36 represents the threshold for gene expression after background thresholding, A chi-squared test in panel A determined significant increase in expression above the background threshold, and Mann-Whitney test determined significance between severe and moderate infection in panels A–C. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Il 36γ Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 36γ antibody/product/Proteintech
    Average 93 stars, based on 1 article reviews
    il 36γ antibody - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    Image Search Results


    IL-36 is elevated in severe bronchiolitis only and is positively correlated with the length of hospitalisation. A) Expression of IL36A , IL36B , and IL36G in moderate (n = 21) and severe (n = 21) bronchiolitis , in RNA isolated from NPAs, and measured by NanoString. B) IL-36 protein levels in nasopharyngeal aspirates from either moderate ( n = 48) or severe ( n = 40) bronchiolitis. C) IL-36 protein levels in nasopharyngeal aspirates (RSV + group) from either moderate (n = 20) or severe (n = 20) RSV infection. D) Protein concentrations of IL-36α in nasosorption samples from healthy controls (grey squares; n = 15), moderate bronchiolitis (blue circles; n = 13) or severe bronchiolitis (red triangles; n = 36). E) Gene expression of IL36A was measured in blood using bulk transcriptomics in healthy infants ( n = 56), or infants with mild ( n = 72), moderate ( n = 92) or severe ( n = 48) RSV infection ( https://doi.org/10.1002/ctm2.1507) . (F) Spearman’s non-parametric correlation and simple linear regression between IL and 36α concentration and the length of hospitalisation. (G) Heatmap of Z-scores of 13 protein mediators measured in NPAs. Both rows and columns were split by K-means clustering. Patients are annotated with peak severity (blue = moderate, red = severe), age, and length of hospital stay (LOS). In panel A the line at y = 5.36 represents the threshold for gene expression after background thresholding, A chi-squared test in panel A determined significant increase in expression above the background threshold, and Mann-Whitney test determined significance between severe and moderate infection in panels A–C. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Journal: Mucosal Immunology

    Article Title: Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis

    doi: 10.1016/j.mucimm.2026.01.012

    Figure Lengend Snippet: IL-36 is elevated in severe bronchiolitis only and is positively correlated with the length of hospitalisation. A) Expression of IL36A , IL36B , and IL36G in moderate (n = 21) and severe (n = 21) bronchiolitis , in RNA isolated from NPAs, and measured by NanoString. B) IL-36 protein levels in nasopharyngeal aspirates from either moderate ( n = 48) or severe ( n = 40) bronchiolitis. C) IL-36 protein levels in nasopharyngeal aspirates (RSV + group) from either moderate (n = 20) or severe (n = 20) RSV infection. D) Protein concentrations of IL-36α in nasosorption samples from healthy controls (grey squares; n = 15), moderate bronchiolitis (blue circles; n = 13) or severe bronchiolitis (red triangles; n = 36). E) Gene expression of IL36A was measured in blood using bulk transcriptomics in healthy infants ( n = 56), or infants with mild ( n = 72), moderate ( n = 92) or severe ( n = 48) RSV infection ( https://doi.org/10.1002/ctm2.1507) . (F) Spearman’s non-parametric correlation and simple linear regression between IL and 36α concentration and the length of hospitalisation. (G) Heatmap of Z-scores of 13 protein mediators measured in NPAs. Both rows and columns were split by K-means clustering. Patients are annotated with peak severity (blue = moderate, red = severe), age, and length of hospital stay (LOS). In panel A the line at y = 5.36 represents the threshold for gene expression after background thresholding, A chi-squared test in panel A determined significant increase in expression above the background threshold, and Mann-Whitney test determined significance between severe and moderate infection in panels A–C. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Article Snippet: Protein levels of IL-36α/IL-1F6 (R&D Systems; #DY1078-05), IL-36γ/IL-1F9 (Adipogen Life Sciences; #AG-46B-0010), and CXCL10/IP-10 (R&D Systems; #DY266) were measured using commercial ELISA kits.

    Techniques: Expressing, Isolation, Infection, Gene Expression, Transcriptomics, Concentration Assay, MANN-WHITNEY

    Neutrophils trigger the release of mucosal IL-36α in vitro . Differential gene expression analysis in human nasal epithelial cell (HNEC) cultures after exposure to A) LPS relative to mock, B) rIL-17A relative to mock, or C) NPA supernatants relative to mock. Genes are coloured depending on whether they were significantly upregulated (red) or downregulated (blue), or not significant (grey) based on the Log 2 fold change and adjusted P values after FDR correction. The cut-off values for the log2 fold change and Benjamini-Yekutieli FDR adjusted P values are 1 and 0.05, respectively. To determine the effect of neutrophils on RSV replication and IL-36 release, inverted HNECs were cultured at air–liquid interface and infected with RSV for 4 h or 24 h, with or without the addition of basolateral neutrophils or recombinant IL-36. D) RSV was measured by RT-qPCR at 4 h or 24 h post-infection of HNECs in culture lysates, in the absence or presence of basolateral neutrophils (for the final 4 h of the infection) or recombinant IL-36. E) IL-36α concentration in the apical washes of HNECs 24 h after infection with RSV, in the absence or presence of basolateral neutrophils. Neutrophils were added either at the time of infection, or 20 h after infection was initiated. In panels D and E, dots are coloured based on HNEC donor (mean of technical duplicates, n = 3) alongside the median of all donors (black line). Statistical significance in panels D and E were measured using ANOVA with Tukey’s correction for multiple comparisons. * = P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Journal: Mucosal Immunology

    Article Title: Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis

    doi: 10.1016/j.mucimm.2026.01.012

    Figure Lengend Snippet: Neutrophils trigger the release of mucosal IL-36α in vitro . Differential gene expression analysis in human nasal epithelial cell (HNEC) cultures after exposure to A) LPS relative to mock, B) rIL-17A relative to mock, or C) NPA supernatants relative to mock. Genes are coloured depending on whether they were significantly upregulated (red) or downregulated (blue), or not significant (grey) based on the Log 2 fold change and adjusted P values after FDR correction. The cut-off values for the log2 fold change and Benjamini-Yekutieli FDR adjusted P values are 1 and 0.05, respectively. To determine the effect of neutrophils on RSV replication and IL-36 release, inverted HNECs were cultured at air–liquid interface and infected with RSV for 4 h or 24 h, with or without the addition of basolateral neutrophils or recombinant IL-36. D) RSV was measured by RT-qPCR at 4 h or 24 h post-infection of HNECs in culture lysates, in the absence or presence of basolateral neutrophils (for the final 4 h of the infection) or recombinant IL-36. E) IL-36α concentration in the apical washes of HNECs 24 h after infection with RSV, in the absence or presence of basolateral neutrophils. Neutrophils were added either at the time of infection, or 20 h after infection was initiated. In panels D and E, dots are coloured based on HNEC donor (mean of technical duplicates, n = 3) alongside the median of all donors (black line). Statistical significance in panels D and E were measured using ANOVA with Tukey’s correction for multiple comparisons. * = P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Article Snippet: Protein levels of IL-36α/IL-1F6 (R&D Systems; #DY1078-05), IL-36γ/IL-1F9 (Adipogen Life Sciences; #AG-46B-0010), and CXCL10/IP-10 (R&D Systems; #DY266) were measured using commercial ELISA kits.

    Techniques: In Vitro, Gene Expression, Cell Culture, Infection, Recombinant, Quantitative RT-PCR, Concentration Assay